miPSC-derived NPC (San Raffaele/University of Milan)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamemiPSC-derived NPC (San Raffaele/University of Milan)
Drug Alias Namemouse pluripotent stem cells-derived neural precursor cells (San Raffaele/University of Milan)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversitá degli Studi di Milano
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIstituto Scientifico H. San RaffaeleUniversitá degli Studi di Milano
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A